Zhizhilashvili Saba, Mchedlishvili Irakli, Camacho Rolando, Jankarashvili Natalia, Garuchava Natalia, Mebonia Nana
Epidemiology and Biostatistics, Tbilisi State Medical University, Tbilisi, GEO.
Global Technical Advisor, City Cancer Challenge Foundation, Geneva, CHE.
Cureus. 2024 Aug 14;16(8):e66862. doi: 10.7759/cureus.66862. eCollection 2024 Aug.
Background Gastric cancer (GC) remains a significant public health issue in many countries globally due to its high morbidity and mortality rates. In Georgia, the incidence of GC reflects the prevalence patterns of established risk factors. To develop appropriate prevention and treatment strategies, GC requires a comprehensive approach and research. This study aims to review and describe GC epidemiologic characteristics in the country. Methodology We conducted a descriptive analysis utilizing data from the national population-based cancer registry. All patients diagnosed with invasive GC between 2015 and 2022 were eligible for inclusion in the analysis. To calculate age-standardized incidence (ASIR) and mortality (ASMR) rates we used a direct method, standardized to the World (WHO 2000-2025) standard population. Trends in Incidence and mortality were assessed using standardized rate ratios (SRRs). The mortality-to-incidence ratio (MIR) was defined as the ratio of the ASMR to the ASIR for the corresponding year. The Kaplan-Meier method was utilized to construct survival curves with survival comparisons performed using the log-rank test. Results A total of 2,707 GC cases with 62% (n = 1,668) of patients being male were enrolled in this descriptive study. The median age at diagnosis was 65 years, and about 70% (n = 1,893) of cases were detected at advanced (III and IV) stages. Over the study period, the ASIR per 100,000 population for both sexes decreased from 8.4 to 7.3. The SRR and 95% confidence interval indicated no significant change in ASIR for males but it decreased for females in 2022 compared to 2015. In 2022, the ASMR decreased compared to 2015 for males (from 10.5 to 7.3/100,00) and for females (from 5.8 to 3.0/100,000) as well. However, the MIR indicated an unstable reduction in mortality, fluctuating over the observation period. The five-year survival rate was around 22.0%. Conclusions This study provides a comprehensive overview of GC epidemiology in Georgia between 2015 and 2022. GC remains a significant public health challenge, characterized by the high proportion of late-stage diagnoses and high mortality rates. The implementation of prevention and early diagnosis strategies is crucial to reduce the burden of GC in the country.
由于胃癌(GC)的高发病率和死亡率,它在全球许多国家仍然是一个重大的公共卫生问题。在格鲁吉亚,胃癌的发病率反映了既定风险因素的流行模式。为了制定适当的预防和治疗策略,胃癌需要综合的方法和研究。本研究旨在回顾和描述该国胃癌的流行病学特征。
我们利用来自全国基于人群的癌症登记处的数据进行了描述性分析。2015年至2022年期间所有被诊断为浸润性胃癌的患者均符合纳入分析的条件。为了计算年龄标准化发病率(ASIR)和死亡率(ASMR),我们使用了直接法,以世界(WHO 2000 - 2025)标准人群为标准进行标准化。发病率和死亡率的趋势使用标准化率比(SRR)进行评估。死亡率与发病率之比(MIR)定义为相应年份的ASMR与ASIR之比。采用Kaplan-Meier方法构建生存曲线,并使用对数秩检验进行生存比较。
本描述性研究共纳入2707例胃癌病例,其中62%(n = 1668)为男性患者。诊断时的中位年龄为65岁,约70%(n = 1893)的病例在晚期(III期和IV期)被检测到。在研究期间,每10万人口中男女的ASIR从8.4降至7.3。SRR和95%置信区间表明男性的ASIR没有显著变化,但与2015年相比,2022年女性的ASIR有所下降。2022年,男性的ASMR与2015年相比有所下降(从10.5降至7.3/10万),女性也是如此(从5.8降至3.0/10万)。然而,MIR表明死亡率呈不稳定下降,在观察期内波动。五年生存率约为22.0%。
本研究全面概述了2015年至2022年格鲁吉亚胃癌的流行病学情况。胃癌仍然是一个重大的公共卫生挑战,其特点是晚期诊断比例高和死亡率高。实施预防和早期诊断策略对于减轻该国胃癌负担至关重要。